Multi Cancer Early Detection by Using Circulating Tumor DNA—The Galleri Test. Reply to Klein et al. The Promise of Multicancer Early Detection. Comment on “Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. <i>Diagnostics</i> 2021, <i>11</i>, 2171”

Multi Cancer Early Detection by Using Circulating Tumor DNA—The Galleri Test. Reply to Klein et al. The Promise of Multicancer Early Detection. Comment on “Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. <i>Diagnostics</i> 2021, <i>11</i>, 2171”

We recently published some concerns with new technologies which are based on circulating tumor DNA (ctDNA) for early cancer detection. Most of our published criticism, including a commentary in this journal, has focused on tests developed by the biotechnology company GRAIL (their commercial product...

Full description

Bibliographic Details
Main Authors: Oscar D. Pons-Belda, Amaia Fernandez-Uriarte, Eleftherios P. Diamandis
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Diagnostics
Subjects:
multi-cancer early detection
methylation assay
circulating tumor DNA
GRAIL
cancer screening
Galleri test
Online Access:https://www.mdpi.com/2075-4418/12/5/1244

Internet

https://www.mdpi.com/2075-4418/12/5/1244

Similar Items